Organizing Committee

Dr. Russel J. Reiter is Professor of Cell Biology in the Department of Cell Systems and Anatomy at the UT Health, San Antonio, Texas, USA, In addition to his Ph.D. degree, Dr. Reiter has received three honorary M.D. degrees and one honorary D.Sc. degree from international universities. His research relates to the multiple receptor-independent and receptor-dependent actions of melatonin in humans, animals and plants. He has trained 25 Ph.D. students and 144 postdoctoral fellows. Dr. Reiter has received numerous awards for his research including the A. Ross McIntyre Gold Metal (USA), US Senior Scientist Award (Germany), Lizoni Lincee Award (Italy), Inaugural Aaron B. Lerner Pioneer Award (USA), Chulabhorn Royal Academy Medal (Thailand), etc. He has published numerous research papers, reviews and chapters and he has written or edited 25 books. Based on Google Scholar, his papers have been cited in the scientific literature more than 130,000 times and his h-index is 175. Thomson Reuters/ Clarivate Analytics have identified Dr. Reiter as a Highly Cited Scientist (top 1%) and listed him as one of the World’s Most Influential Scientific Minds in 2014. Dr. Reiter has been an invited speaker at more than 300 international meetings and symposia. He is the Co-Editor of Melatonin Research and he is the Founder and past Editor of the Journal of Pineal Research.

Dr. Russel J. Reiter is Professor of Cell Biology in the Department of Cell Systems and Anatomy at the UT Health, San Antonio, Texas, USA, In addition to his Ph.D. degree, Dr. Reiter has received three honorary M.D. degrees and one honorary D.Sc. degree from international universities. His research relates to the multiple receptor-independent and […]

Weon-Kyoo You received his PhD majored in Biochemistry at Yonsei University in 2004. Then, he worked as a postdoctoral fellow at UC San Francisco, and as a researcher at Sanford-Burnham Prebys Medical Discovery Institute from 2004 to 2012. He successfully performed several research projects and published many peer-reviewed papers in the field of tumor-induced angiogenesis and tumor microenvironments. After he came back to Korea, he joined at the Hanwha Chemical, R&D center as a principal research scientist to discover and develop a novel bispecific antibody until March, 2016. Currently he is working as the R&D Head at a startup biotech company, ABL Bio, Inc. and leading new antibody-based drug development projects.

Weon-Kyoo You received his PhD majored in Biochemistry at Yonsei University in 2004. Then, he worked as a postdoctoral fellow at UC San Francisco, and as a researcher at Sanford-Burnham Prebys Medical Discovery Institute from 2004 to 2012. He successfully performed several research projects and published many peer-reviewed papers in the field of tumor-induced angiogenesis […]

Prof. Dr. Dr.-Ing. Jürgen Lademann is an internationally renowned scientist researching at the interface between dermatology, pharmacology and biophysics. Since 1996 the physicist has been in charge of the Center of Experimental and Applied Cutaneous Physiology at the Department of Dermatology, Venerology and Allergology of the Charité – Universitätsmedizin Berlin. In 2001 he was appointed Professor of Dermatology.
He authored and co-authored more than 700 articles in peer-reviewed scientific journals.
He is the President of the “International Foundation of Societies of cosmetic Chemists – IFSCC” and he was the president of the IFSCC Congress 2018 in Munich and many other conferences.

Prof. Dr. Dr.-Ing. Jürgen Lademann is an internationally renowned scientist researching at the interface between dermatology, pharmacology and biophysics. Since 1996 the physicist has been in charge of the Center of Experimental and Applied Cutaneous Physiology at the Department of Dermatology, Venerology and Allergology of the Charité – Universitätsmedizin Berlin. In 2001 he was appointed […]

Dr. Jason X. Cheng stayed at University of Chicago to get his Hematopathology fellow under the guidance of Dr. James W. Vardiman, one of the top authorities in Diagnostic Hematopathology. He completed his fellowship training in 2010, and then became an assistant Professor in University of Michigan at Ann Arbor where he was the head of Epigenetics Laboratory.

Dr. Cheng came back to become a faculty in the Hematopathology Section at University of Chicago in 2013. He has quite a few scientific publications and a patent issued by the U.S. patent agency. He also had multiple awards including Cancer Research Foundation Young Investigator Award, the society for Hematopathology Pathologist-in-Training Award, the Paul E. Strandjord Young Investigator Award from Academy of Clinical Physicians and Scientists, the Robert E. Priest Fellowship

Dr. Jason X. Cheng stayed at University of Chicago to get his Hematopathology fellow under the guidance of Dr. James W. Vardiman, one of the top authorities in Diagnostic Hematopathology. He completed his fellowship training in 2010, and then became an assistant Professor in University of Michigan at Ann Arbor where he was the head […]

Dr. Wei Han completed his Ph.D. in Molecular Biology from Mount Sinai School of Medicine at NYC in 1994 followed by a postdoctoral training at Memorial Sloan-Kettering Cancer Center. He is now a professor at Shanghai Jiao Tong University and Founder of General Regeneratives (Shanghai) Ltd. He developed a proprietary “Prometheus Technology” to discover genes important for multiple tissue regeneration and repair, including bone marrow, liver, pancreas, cartilage, gut epithelial, and thymus. Over the years, a series of investigational new drugs were developed. The most advanced candidate with global patents, GR007, a multi-organ protector against chemotoxicities has demonstrated its good safety profile and preliminary efficacy in phase 1 clinical trial, and phase 2 clinical trial is ongoing.

Dr. Wei Han completed his Ph.D. in Molecular Biology from Mount Sinai School of Medicine at NYC in 1994 followed by a postdoctoral training at Memorial Sloan-Kettering Cancer Center. He is now a professor at Shanghai Jiao Tong University and Founder of General Regeneratives (Shanghai) Ltd. He developed a proprietary “Prometheus Technology” to discover genes […]

I have a long-standing interest in cancer metastasis and from 1987, my main research interest has been on the molecular and cellular basis of cancer invasion and metastasis and therapeutic aspects of targeting cancer metastasis. I have been particularly interested in the bone, peritoneal and brain metastasis from primary tumours including breast, prostate, lung, GI cancers. My research has been conducted in Cardiff’s School of Medicine and I have collaborated widely with colleagues in the UK, China, Europe, North America and Asia.

I have a long-standing interest in cancer metastasis and from 1987, my main research interest has been on the molecular and cellular basis of cancer invasion and metastasis and therapeutic aspects of targeting cancer metastasis. I have been particularly interested in the bone, peritoneal and brain metastasis from primary tumours including breast, prostate, lung, GI […]

Angiolo Gadducci is currently working as Professor at Department of Obstetrics and Gynecology, University of Pisa, Italy. He has extended his valuable service as oncologist has been a recipient of many award and grants. His international experience includes various programs, contributions and participation in different countries for diverse fields
of study. His research interests reflect in his wide range of publications in various national and international journals.

Angiolo Gadducci is currently working as Professor at Department of Obstetrics and Gynecology, University of Pisa, Italy. He has extended his valuable service as oncologist has been a recipient of many award and grants. His international experience includes various programs, contributions and participation in different countries for diverse fields of study. His research interests reflect […]

Matteo Ruggeri (born in 1976) gained his first degree in Economics at the University of Rome “Tor Vergata” in 2001 with a final dissertation in Econometrics. In 2002 he gained a Msc in Economics and in 2003 a MA in Business Engineering both at the University of Rome “Tor Vergata”. In 2004 he was visiting scholar at the Thomas Jefferson University (PA-U.S.A.) and in 2005 at the University of Aberdeen and at the University of York (UK). In 2006 he gained a Phd in Health Economics at the Università Cattolica del Sacro Cuore (UCSC). Since 2007 he was lecturer in Health Economics and Pharmacoeconomics at UCSC where is actually Assistant Professor of Policy and Economics (RTD-a, SECS-P02). He is project leader at ALTEMS (UCSC Graduate School in Health Economics and Management) and he teaches several graduate courses in Health Economics and Pharmacoeconomics. His main research interests focus on Experimental Economics and decision modeling in the field of healthcare and Health Technology Assessment. He participates in several research projects both funded by industry and national and international institutions (Italian Ministry of Health, Italian local health authorities and EU commission). He has published approximately 25 papers on peer reviewed international and national journals including top health economics journals (Journal of Health Economics, Value in Health, Health Policy, International Journal of Technology Assessment in Healthcare). He frequently participates in national and international conferences of economics and health economics. He is member of several scientific and editorial boards and he serves as reviewer of many journals including Journal of Health Economics, Value in Health, International Journal of Public Health, Health Risk and Society, Pharmacoeconomics –It Res Art. In december 2013, he gained the national qualification (Abilitazione Scientifica Nazionale) for Associate Professor in Policy and Economics. He is an auxiliary Officer (Lieutenant) of the Italian Red Cross Military Corps. He is married with two children.

Matteo Ruggeri (born in 1976) gained his first degree in Economics at the University of Rome “Tor Vergata” in 2001 with a final dissertation in Econometrics. In 2002 he gained a Msc in Economics and in 2003 a MA in Business Engineering both at the University of Rome “Tor Vergata”. In 2004 he was visiting […]

M.Garofalo got a PhD in Biochemistry and Cell and Molecular Biology in 2015 from University Federico II of Naples (Italy) with a foreign co-advisor from University of Helsinki (Finland). After a post-doc at University of Helsinki, her current research is focused on the definition of tools and techniques to improve the delivery of biological drugs and chemotherapeutic agents using oncolytic adenoviruses and extracellular vesicles

M.Garofalo got a PhD in Biochemistry and Cell and Molecular Biology in 2015 from University Federico II of Naples (Italy) with a foreign co-advisor from University of Helsinki (Finland). After a post-doc at University of Helsinki, her current research is focused on the definition of tools and techniques to improve the delivery of biological drugs […]

Vivienne Zhu, MD, MS is an assistant professor in the Biomedical Informatics Center (BMIC) at the Medical University of South Carolina (MUSC). Dr. Zhu’s major research area is improving quality of care and health outcomes for patients with chronic conditions using health information technology (HIT). Her expertise incldue computerized clinical decision support (CDSS), electrinic health record (EHR), natural languge processing (NLP) for clincal appliaitons, and predictive analytics. At MUSC, using NLP technology, Dr. Zhu led effort of measuring compliance rate of the Joint Commission standards for critical results reporting and communication and the CMS quality of care reporting. Dr. Zhu is the pricinple investigator and co-investigator for serveral NIH funded studies. She leads an NLP project of identifying and extracting social determinates from clinical notes for prostaet cancer patients. Dr.Zhu has published a nubmer of peer-reviewed scientific papers on medical informatics, patient safety, and health outcomes research.

Vivienne Zhu, MD, MS is an assistant professor in the Biomedical Informatics Center (BMIC) at the Medical University of South Carolina (MUSC). Dr. Zhu’s major research area is improving quality of care and health outcomes for patients with chronic conditions using health information technology (HIT). Her expertise incldue computerized clinical decision support (CDSS), electrinic health […]

Mulu completed her PhD in human biology at the Department of Internal Medicine Ludwig Maximilians University (LMU), Munich, Germany. Her project focused on the examination of the targets of the fusion protein transcription factor PML-RARα and C/EBPα, which are involved in the pathogenesis of Acute Promyelocytic Leukemia (APL) and Acute Myeloid Leukemia(AML). In 2007 Mulu joined Dr. Leda Raptis’s lab as a postdoctoral fellow and was working on the Investigation of the novel pathway of Stat3 activation that is triggered by cadherin engagement.

Since September 2013 has worked as a postdoctoral scientist at the University of Toronto in Dr. Gunning’s lab conducting cellular biology. Mulu performs screening of the in-house libraries of STAT’s proteins inhibitors using high-throughput cell basedcytotoxicity assay.

Mulu’s postdoctoral experiences have encompassed studying signal transduction in normal and tumour cells, specifically investigating the role of the STAT3/STAT5 pathways.

Mulu completed her PhD in human biology at the Department of Internal Medicine Ludwig Maximilians University (LMU), Munich, Germany. Her project focused on the examination of the targets of the fusion protein transcription factor PML-RARα and C/EBPα, which are involved in the pathogenesis of Acute Promyelocytic Leukemia (APL) and Acute Myeloid Leukemia(AML). In 2007 Mulu […]

Marianna Pannico is a researcher at the Institute for Polymers, Composites and Biomaterials (IPCB) of the National Research Council of Italy. She is doctor in Chemistry and in 2010 she got her Ph.D in Materials and Structures Engineering at University of Napoli “Federico II”. She is an Adjunct Assistant Professor of Chemistry and Math at “University of Maryland University College (UMUC)” Europe. She does research in Physical Chemistry, Polymer Chemistry and Materials Chemistry. Her research activity in mainly focused on plasmonic nanomaterials for the analytical and bio-sensing applications of SERS spectroscopy. She is an expert of Raman Spectroscopy, confocal Raman imaging, Surface Enhanced Raman Spectroscopy (SERS) and Infrared spectroscopy (FTIR, FT-NIR, IR microspectroscopy). She is really interested in theranostic applications of metallic nanoparticles in nanomedicine.

Marianna Pannico is a researcher at the Institute for Polymers, Composites and Biomaterials (IPCB) of the National Research Council of Italy. She is doctor in Chemistry and in 2010 she got her Ph.D in Materials and Structures Engineering at University of Napoli “Federico II”. She is an Adjunct Assistant Professor of Chemistry and Math at […]